SCHEMBL12800930

SCHEMBL12800930

Nc1cc(-c2ccnc(Nc3ccc(F)c(F)c3)n2)ccc1O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 3/20 0.51
▸ IKBKB O14920 3/20 0.50
▸ CHUK O15111 1/20 0.50
▸ GSK3B P49841 7/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ CAMK2D Q13557 3/20 0.47
▸ EIF2AK2 P19525 1/20 0.47
▸ CLK1 P49759 1/20 0.46
▸ CLK2 P49760 1/20 0.46
▸ DYRK1A Q13627 1/20 0.46
▸ CLK4 Q9HAZ1 1/20 0.46
▸ DYRK1B Q9Y463 1/20 0.46
▸ JAK2 O60674 1/20 0.45
▸ FLT3 P36888 1/20 0.45
▸ DKK1 O94907 1/20 0.45
▸ ABL1 P00519 1/20 0.44
▸ BCR P11274 1/20 0.44
▸ SRC P12931 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12801690 0.85 PIK3CG (0.54) PLK1GSK3BCDK2CAMK2DJAK2
SCHEMBL27116134 0.84 GSK3B (0.52) PLK1IKBKBCHUKGSK3BCDK2
SCHEMBL12801692 0.83 PLK1 (0.51) PLK1IKBKBGSK3BCDK2CAMK2D
SCHEMBL14254230 0.83 CAMK2D (0.59) PLK1IKBKBGSK3BCAMK2DJAK2
SCHEMBL14254277 0.82 CAMK2D (0.71) PLK1CDK2CAMK2DJAK2FLT3
SCHEMBL14254278 0.81 SRC (0.55) PLK1IKBKBGSK3BCDK2CAMK2D
SCHEMBL12801101 0.81 JAK2 (0.58) PLK1IKBKBGSK3BCDK2JAK2
SCHEMBL16941489 0.78 ABL1 (0.61) PLK1IKBKBCHUKGSK3BCDK2
SCHEMBL14254228 0.77 PIK3CG (0.71) PLK1IKBKBGSK3BCDK2DYRK1A
SCHEMBL12801126 0.77 JAK2 (0.52) PLK1GSK3BCAMK2DJAK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011046970-A1 AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON MYREXIS, INC. (US) 2011-04-21 — — WO disclosed
Send feedback